Barclays’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-218,095
| Closed | -$33M | – | 4842 |
|
|
2022
Q3 | $33M | Buy |
218,095
+107,352
| +97% | +$16.2M | 0.04% | 428 |
|
|
2022
Q2 | $16.1M | Buy |
110,743
+101,146
| +1,054% | +$14.7M | 0.01% | 659 |
|
|
2022
Q1 | $1.14M | Sell |
9,597
-58,008
| -86% | -$6.88M | ﹤0.01% | 2210 |
|
|
2021
Q4 | $9.32M | Buy |
67,605
+44,756
| +196% | +$6.17M | ﹤0.01% | 919 |
|
|
2021
Q3 | $3.17M | Buy |
22,849
+14,335
| +168% | +$1.99M | ﹤0.01% | 1537 |
|
|
2021
Q2 | $826K | Sell |
8,514
-31,734
| -79% | -$3.08M | ﹤0.01% | 2217 |
|
|
2021
Q1 | $2.75M | Sell |
40,248
-79,389
| -66% | -$5.43M | ﹤0.01% | 1637 |
|
|
2020
Q4 | $10.3M | Buy |
119,637
+97,454
| +439% | +$8.35M | 0.01% | 774 |
|
|
2020
Q3 | $1.44M | Sell |
22,183
-8,961
| -29% | -$582K | ﹤0.01% | 1699 |
|
|
2020
Q2 | $2.28M | Sell |
31,144
-168,260
| -84% | -$12.3M | ﹤0.01% | 1393 |
|
|
2020
Q1 | $6.79M | Buy |
199,404
+9,311
| +5% | +$317K | 0.01% | 755 |
|
|
2019
Q4 | $10.3M | Buy |
190,093
+170,812
| +886% | +$9.3M | 0.01% | 830 |
|
|
2019
Q3 | $804K | Sell |
19,281
-3,391
| -15% | -$141K | ﹤0.01% | 2378 |
|
|
2019
Q2 | $993K | Sell |
22,672
-42,873
| -65% | -$1.88M | ﹤0.01% | 2341 |
|
|
2019
Q1 | $3.37M | Buy |
65,545
+65,222
| +20,193% | +$3.36M | ﹤0.01% | 1214 |
|
|
2018
Q4 | $12K | Sell |
323
-12,784
| -98% | -$475K | ﹤0.01% | 3514 |
|
|
2018
Q3 | $492K | Buy |
13,107
+1,661
| +15% | +$62.3K | ﹤0.01% | 2646 |
|
|
2018
Q2 | $452K | Sell |
11,446
-35,505
| -76% | -$1.4M | ﹤0.01% | 2345 |
|
|
2018
Q1 | $1.21M | Buy |
46,951
+43,768
| +1,375% | +$1.13M | ﹤0.01% | 1665 |
|
|
2017
Q4 | $86K | Buy |
3,183
+1,741
| +121% | +$47K | ﹤0.01% | 3085 |
|
|
2017
Q3 | $54K | Buy |
1,442
+1,434
| +17,925% | +$53.7K | ﹤0.01% | 2927 |
|
|
2017
Q2 | $0 | Buy |
+8
| New | – | ﹤0.01% | 4373 |
|